CVS Health Rises 1.55% on Medicare Reforms and Retail Expansion Trading Volume Drops 28% to Rank 275th

On September 26, 2025, CVS Health Corp (CVS) closed up 1.55% with a trading volume of $370 million, representing a 28.09% decline from the previous day’s volume. The stock ranked 275th in terms of trading activity among listed equities.

Recent developments suggest mixed sentiment for the pharmacy giant. A regulatory filing highlighted potential cost pressures from upcoming Medicare Part D reforms, which could impact prescription drug margins. Meanwhile, a separate report underscored CVS’s expansion of its retail health clinics, signaling a strategic pivot toward diversified healthcare services. Analysts noted the dual influence of policy risks and operational initiatives on investor positioning.

Market participants are closely monitoring the company’s response to evolving healthcare regulations, particularly as proposed changes to reimbursement rates may compress profitability. However, the acceleration of in-store health services could offset some of these challenges by attracting new customer segments and enhancing foot traffic.

To run this back-test properly we need to pin down a few practical details: Market universe, pricing convention, weighting & capital allocation, transaction costs, and benchmark. Once these points are set, the back-test can be executed from January 1, 2022, to the present.